169 related articles for article (PubMed ID: 2503477)
1. Antitumor effect of interleukin-1 beta in the double grafted tumor system.
Ebina T; Ishikawa K
Jpn J Cancer Res; 1989 Jun; 80(6):570-6. PubMed ID: 2503477
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic effect of biological response modifiers in the "double grafted tumor system".
Ebina T; Kohya H; Yamaguchi T; Ishida N
Jpn J Cancer Res; 1986 Oct; 77(10):1034-42. PubMed ID: 3096919
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of PSK (2): effector mechanism of the antimetastatic effect in the "double grafted tumor system"].
Ebina T; Kohya H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1847-53. PubMed ID: 3592718
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
Ebina T; Shishido K; Murata K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effect of Cepharanthin in the double grafted tumor system].
Ebina T; Ishikawa K; Murata K
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1165-71. PubMed ID: 2350192
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effector mechanism of interleukin-1 beta at a distant site in the double grafted tumor system.
Ebina T; Murata K
Jpn J Cancer Res; 1991 Nov; 82(11):1292-8. PubMed ID: 1752785
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor effect of PSK (1). Interferon-inducing activity and intratumoral administration].
Ebina T; Kohya H; Inoue H; Aso H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1841-6. PubMed ID: 2439019
[TBL] [Abstract][Full Text] [Related]
8. The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMs.
Kohya H; Ebina T; Yamaguchi T; Ishida N
Biotherapy; 1989; 1(3):139-51. PubMed ID: 2534966
[TBL] [Abstract][Full Text] [Related]
9. [Differences of antitumor effect of various BRMs by intratumoral administration].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1429-32. PubMed ID: 1530288
[TBL] [Abstract][Full Text] [Related]
10. [Regional adoptive immunotherapy using activated lymphocytes].
Ebina T; Isono N; Murata K; Yokoyama J; Mikuni J; Ohuchi K
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1549-52. PubMed ID: 8854802
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.
Ebina T; Kohya H
Jpn J Cancer Res; 1988 Aug; 79(8):957-64. PubMed ID: 3141330
[TBL] [Abstract][Full Text] [Related]
12. [Differences in antitumor effect of various BRMs by intratumoral administration: induction of immunosuppressive acidic protein].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1453-6. PubMed ID: 8373204
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of intratumoral administration of biological response modifiers: induction of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in mice.
Ebina T; Murata K; Tamura K
Jpn J Cancer Res; 1994 Jan; 85(1):93-100. PubMed ID: 8106294
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumors.
Belardelli F; Ciolli V; Testa U; Montesoro E; Bulgarini D; Proietti E; Borghi P; Sestili P; Locardi C; Peschle C
Int J Cancer; 1989 Dec; 44(6):1108-16. PubMed ID: 2606579
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice.
Ebina T; Fujimiya Y
Biotherapy; 1998; 11(4):259-65. PubMed ID: 9950102
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of PSK at a distant site: inductions of interleukin-8-like factor and macrophage chemotactic factor in murine tumor.
Ebina T; Murata K
Jpn J Cancer Res; 1990 Dec; 81(12):1307-13. PubMed ID: 2126000
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor Effector mechanism of plant alkaloid preparation, cepharanthin, by intratumoral administration].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1812-6. PubMed ID: 1877822
[TBL] [Abstract][Full Text] [Related]
18. Adoptive immunotherapy in tumor-bearing mice with OK-432-induced killer cells.
Ujiie T
Jpn J Exp Med; 1988 Apr; 58(2):109-14. PubMed ID: 3261814
[TBL] [Abstract][Full Text] [Related]
19. Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumors.
Mattijssen V; Balemans LT; Steerenberg PA; De Mulder PH
Int J Cancer; 1992 Jul; 51(5):812-7. PubMed ID: 1612787
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of antitumor effect on syngeneic murine solid tumors by an interleukin 2 slow delivery system, the IL-2 mini-pellet.
Fujiwara T; Sakagami K; Matsuoka J; Shiozaki S; Fujioka K; Takada Y; Uchida S; Onoda T; Orita K
Biotherapy; 1991; 3(3):203-9. PubMed ID: 1854589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]